stable cell lines (CLS Cell Lines Service GmbH)
94
Structured Review
CLS Cell Lines Service GmbH
stable cell lines
Stable Cell Lines, supplied by CLS Cell Lines Service GmbH, used in various techniques. Bioz Stars score: 94/100, based on 14 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stable+cell+lines/786-O+Cells/pm42246926-1017-0-18
Average 94 stars, based on 14 article reviews
Stable Cell Lines, supplied by CLS Cell Lines Service GmbH, used in various techniques. Bioz Stars score: 94/100, based on 14 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stable+cell+lines/786-O+Cells/pm42246926-1017-0-18
Average 94 stars, based on 14 article reviews
stable cell lines - by Bioz Stars,
2026-11
94/100 stars
Images
Related Articles
Stable Transfection:Article Title: Discovery of Casdatifan, Part II: A Potent and Orally Bioavailable Inhibitor of Hypoxia Inducible Factor-2α. Article Snippet: Hypoxia-inducible factor 2α (HIF-2α) is recognized as a key oncogenic driver in clear cell renal cell carcinoma (ccRCC), the most prevalent type of kidney cancer.. Here, we describe the discovery of a highly potent and selective tetralin-based HIF-2α inhibitor, casdatifan (61), originating from previously identified tetrahydroquinolines reported in the Part 1 companion manuscript.. Casdatifan demonstrates a potentially best-in-class clinical profile. Generated:Article Title: Discovery of Casdatifan, Part II: A Potent and Orally Bioavailable Inhibitor of Hypoxia Inducible Factor-2α. Article Snippet: Hypoxia-inducible factor 2α (HIF-2α) is recognized as a key oncogenic driver in clear cell renal cell carcinoma (ccRCC), the most prevalent type of kidney cancer.. Here, we describe the discovery of a highly potent and selective tetralin-based HIF-2α inhibitor, casdatifan (61), originating from previously identified tetrahydroquinolines reported in the Part 1 companion manuscript.. Casdatifan demonstrates a potentially best-in-class clinical profile. |